Lilly Bamlanivimab Antibody Playbook
This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.
Related Content
When Millimeters Matter: Pharmacy Teams Power Pediatric Care
Why 340B Is Essential for Children's Health
Unlocking Hope with Improved Access to Gene Therapy
When Millimeters Matter: Pharmacy Teams Power Pediatric Care
Pharmacy teams at children’s hospitals handle tens of millions of medication doses for our nation's kids.
Why 340B Is Essential for Children's Health
The program makes life-saving drugs more affordable for hospitals that care for our nation’s children.
Unlocking Hope with Improved Access to Gene Therapy
The promise of CGTs is tempered by their staggering cost and treatment complexity.
